Os Therapies Incorporated Stock Performance
| OSTX Stock | 1.20 0.03 2.56% |
The company owns a Beta (Systematic Risk) of 1.65, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, OS Therapies will likely underperform. At this point, OS Therapies has a negative expected return of -0.53%. Please make sure to check OS Therapies' potential upside, day median price, and the relationship between the treynor ratio and accumulation distribution , to decide if OS Therapies performance from the past will be repeated sooner or later.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days OS Therapies Incorporated has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2026. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
1 | OS Therapies Gets INN daznelimgene lisbac for OST-HER2 Cancer Therapy - Stock Titan | 11/25/2025 |
2 | Disposition of 100000 shares by Bologna Thomas A of OS Therapies at 1. subject to Rule 16b-3 | 11/28/2025 |
3 | OS Therapies granted FDA fee waiver and EMA Union Marketing Authorisation eligibility - Stock Titan | 12/05/2025 |
4 | OS Therapies targets Jan. 2026 BLA after FDA Type C talks - Stock Titan | 12/15/2025 |
5 | Can OS Therapies Incorporated stock beat analyst upgrades - Value Stock Picks High Profit Market Growth - bollywoodhelpline.com | 12/26/2025 |
6 | OS Therapies Provides First Half 2026 Corporate Outlook - FinancialContent | 01/05/2026 |
7 | OS Therapies Announces Filing Form S-1 of OS Animal Health Subsidiary - FinancialContent | 01/14/2026 |
8 | Market Catalysts How does HNRG compare to its peers - July 2025 Spike Watch Low Volatility Stock Suggestions - baoquankhu1.vn | 01/28/2026 |
9 | OS Therapies Receives Buy Rating from D. Boral Capital | 02/05/2026 |
10 | OS Therapies Discloses 2026 Timeline For Lead Drug Regulatory Filings - Benzinga | 02/17/2026 |
OS Therapies Relative Risk vs. Return Landscape
If you would invest 172.00 in OS Therapies Incorporated on November 22, 2025 and sell it today you would lose (52.00) from holding OS Therapies Incorporated or give up 30.23% of portfolio value over 90 days. OS Therapies Incorporated is currently does not generate positive expected returns and assumes 3.964% risk (volatility on return distribution) over the 90 days horizon. In different words, 35% of stocks are less volatile than OSTX, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
OS Therapies Target Price Odds to finish over Current Price
The tendency of OSTX Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 1.20 | 90 days | 1.20 | over 95.22 |
Based on a normal probability distribution, the odds of OS Therapies to move above the current price in 90 days from now is over 95.22 (This OS Therapies Incorporated probability density function shows the probability of OSTX Stock to fall within a particular range of prices over 90 days) .
OS Therapies Price Density |
| Price |
Predictive Modules for OS Therapies
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as OS Therapies. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of OS Therapies' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
OS Therapies Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. OS Therapies is not an exception. The market had few large corrections towards the OS Therapies' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold OS Therapies Incorporated, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of OS Therapies within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.65 | |
β | Beta against Dow Jones | 1.65 | |
σ | Overall volatility | 0.21 | |
Ir | Information ratio | -0.16 |
OS Therapies Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of OS Therapies for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for OS Therapies can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| OS Therapies generated a negative expected return over the last 90 days | |
| OS Therapies may become a speculative penny stock | |
| OS Therapies has high historical volatility and very poor performance | |
| OS Therapies has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (8.88 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| OS Therapies generates negative cash flow from operations | |
| OS Therapies has a frail financial position based on the latest SEC disclosures | |
| About 28.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: OS Therapies Discloses 2026 Timeline For Lead Drug Regulatory Filings - Benzinga |
OS Therapies Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of OSTX Stock often depends not only on the future outlook of the current and potential OS Therapies' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. OS Therapies' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 20.9 M | |
| Cash And Short Term Investments | 5.5 M |
OS Therapies Fundamentals Growth
OSTX Stock prices reflect investors' perceptions of the future prospects and financial health of OS Therapies, and OS Therapies fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on OSTX Stock performance.
| Return On Equity | -9.14 | ||||
| Return On Asset | -2.25 | ||||
| Current Valuation | 59.56 M | ||||
| Shares Outstanding | 35.21 M | ||||
| Price To Book | 11.81 X | ||||
| EBITDA | (6.83 M) | ||||
| Net Income | (8.88 M) | ||||
| Total Debt | 6.05 M | ||||
| Book Value Per Share | 0.11 X | ||||
| Cash Flow From Operations | (7.28 M) | ||||
| Earnings Per Share | (0.81) X | ||||
| Market Capitalization | 41.2 M | ||||
| Total Asset | 5.54 M | ||||
| Retained Earnings | (40.4 M) | ||||
| Working Capital | 906.22 K | ||||
About OS Therapies Performance
Evaluating OS Therapies' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if OS Therapies has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if OS Therapies has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.44) | (1.52) | |
| Return On Capital Employed | (8.60) | (8.17) | |
| Return On Assets | (1.44) | (1.52) | |
| Return On Equity | (12.59) | (11.96) |
Things to note about OS Therapies performance evaluation
Checking the ongoing alerts about OS Therapies for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for OS Therapies help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| OS Therapies generated a negative expected return over the last 90 days | |
| OS Therapies may become a speculative penny stock | |
| OS Therapies has high historical volatility and very poor performance | |
| OS Therapies has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (8.88 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| OS Therapies generates negative cash flow from operations | |
| OS Therapies has a frail financial position based on the latest SEC disclosures | |
| About 28.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: OS Therapies Discloses 2026 Timeline For Lead Drug Regulatory Filings - Benzinga |
- Analyzing OS Therapies' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether OS Therapies' stock is overvalued or undervalued compared to its peers.
- Examining OS Therapies' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating OS Therapies' management team can have a significant impact on its success or failure. Reviewing the track record and experience of OS Therapies' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of OS Therapies' stock. These opinions can provide insight into OS Therapies' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for OSTX Stock Analysis
When running OS Therapies' price analysis, check to measure OS Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OS Therapies is operating at the current time. Most of OS Therapies' value examination focuses on studying past and present price action to predict the probability of OS Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OS Therapies' price. Additionally, you may evaluate how the addition of OS Therapies to your portfolios can decrease your overall portfolio volatility.